Disease Specific Interactions between Host Protein and DME (HOSPPI) |
ICD Disease Classification 02 Neoplasms |
ICD-11: 2C12 Liver cancer |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
Histone modification |
Histone deacetylases (HDACs) |
Liver cancer |
Repression |
Uniprot ID |
|
Interaction Name |
HDACs-NAT1 interaction |
[1] |
Studied Cell Lines |
HepG2 cell line |
Description |
Histone deacetylases (HDACs) are reported to deacetylate the NAT1 gene and thereby repress the transcriptional activity of the drug-metabolizing enzyme N-acetyltransferase 1. As a result, the interaction between HDACs and NAT1 can inhibit the drug-metabolizing process of N-acetyltransferase 1. |
ICD-11: 2C60 Breast cancer |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
Transcription-factor regulation |
Androgen receptor (AR) |
Breast cancer |
Activation |
Uniprot ID |
|
Interaction Name |
AR-NAT1 interaction |
[2] |
Studied Cell Lines |
MCF10A and MCF7 cell lines |
Ensembl ID |
|
Description |
Androgen receptor (AR) is reported to activate the transcription of NAT1 gene, which leads to an increased expression of the drug-metabolizing enzyme N-acetyltransferase 1. As a result, the interaction between AR and NAT1 can activate the drug-metabolizing process of N-acetyltransferase 1. |
ICD-11: 2C82 Prostate cancer |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
Transcription-factor regulation |
Heat shock factor 1 (HSF1) |
Prostate cancer |
Activation |
Uniprot ID |
|
Interaction Name |
HSF1-NAT1 interaction |
[3] |
Studied Cell Lines |
22Rv1 cell line |
Ensembl ID |
|
Description |
Heat shock factor 1 (HSF1) is reported to activate the transcription of NAT1 gene, which leads to an increased expression of the drug-metabolizing enzyme N-acetyltransferase 1. As a result, the interaction between HSF1 and NAT1 can activate the drug-metabolizing process of N-acetyltransferase 1. |
|
|
|
|
|
|